Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2023 Apr 20;42:94. doi: 10.1186/s13046-023-02662-9

Retraction Note: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway

Zizhuo Li 1,#, Yaodong Chen 1,#, Tingting An 1, Pengfei Liu 2, Jiyuan Zhu 3, Haichao Yang 1, Wei Zhang 1, Tianxiu Dong 1, Jian Jiang 1, Yu Zhang 1, Maitao Jiang 1, Xiuhua Yang 1,
PMCID: PMC10116673  PMID: 37081544

Retraction Note: J Exp Clin Cancer Res 38, 139 (2019)

https://doi.org/10.1186/s13046-019-1134-y

The Editor-in-Chief has retracted this article. Concerns have been raised about Fig. 3a, specifically:

  • The 0h control panels for U87 and U251 appear to be identical

  • The 0h NF 25µM panels for U87 and NF 25µM appear to be identical

  • The 0h NF 30 µM panels for U87 and U251 appear to partially overlap

  • The 24h control panels for U87 and U251 appear to be identical

  • The 24h NF 25 µM panels for U87 and U251 appear to partially overlap

  • The 24h NF 30 µM panels for U87 and U251 appear to partially overlap

  • The 48h control panels for U87 and U251 appear to partially overlap

  • The 48 NF 25 µM panels for U87 and U251 appear to be identical

The Editor-in-Chief therefore no longer have confidence in the results and conclusions of this article.

Authors Zizhuo Li and Xiuhua Yang agree with this retraction. The other authors have not responded to correspondence regarding this retraction.

Footnotes

The online version of the original article can be found at 10.1186/s13046-019-1134-y

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Zizhuo Li and Yaodong Chen are CO-first authors with equal contribution to the manuscript.


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES